Summary:
Click image to enlarge
The SEMA-NASH study (NN9931-4296) is looking at a medication called semaglutide that is being investigated for treatment of people with non-alcoholic steatohepatitis or NASH. It involves 14 visits to the clinic and 5 telephone contacts over approximately 85 weeks.
Qualified Participants Must:
• Be 18-75 years of age
•
Have confirmed non-alcoholic steatohepatitis
•
Able to attend clinic appointments and phone contacts throughout the study
Qualified Participants May Receive:
Eligible participants will receive compensation, medical care and regular health checks.